Cell cycle regulators at the ocular surface

Experimental Eye Research

Volumn 78, Issue 3, 2004, Pages 447-456

  Zieske, James D ^a   Francesconi, Claudia M ^a   Guo, Xiaoqing ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Cell cycle; Cell proliferation; Cyclin; Cyclin dependent kinase; Cyclin dependent kinase inhibitor; Retinoblastoma protein

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; PROTEIN P107; PROTEIN P130; PROTEIN P15; PROTEIN P16; PROTEIN P18; PROTEIN P19; PROTEIN P21; PROTEIN P27; PROTEIN P57; RETINOBLASTOMA PROTEIN;

BASAL CELL; CELL CYCLE; CELL PROLIFERATION; CELL SURFACE; CONJUNCTIVA; CORNEA; CORNEA CELL; ENDOTHELIUM CELL; HOMEOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SURFACE PROPERTY; WOUND HEALING;

EID: 0842310254     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4835(03)00205-7     Document Type: Article

References (64)

1. Arey L.B., Covode W.M. The method of repair in epithelial wounds of the cornea. Anat. Rec. 86:1943;75-86.
2. Bagella L., MacLachlan T.K., Buono R.J., Pisano M.M., Giordano A., De Luca A. Cloning of murine CDK9/PITALRE and its tissue-specific expression in development. J. Cell Physiol. 177:1998;206-213.
3. Blint E., Phillips A.C., Kozlov S., Stewart C.L., Vousden K.H. Induction of p57(KIP2) expression by p73beta. Proc. Nat. Acad. Sci. USA. 99:2002;3529-3534.
4. Carnero A., Hannon G.J. The INK4 family of CDK inhibitors. Curr. Top. Microbiol. Immunol. 227:1998;43-55.
5. Chellappan S.P., Giordano A., Fisher P.B. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development. Curr. Top. Microbiol. Immunol. 227:1998;57-103.
6. Chung E.-H., Hutcheon A.E.K., Joyce N.C., Zieske J.D. Synchronization of the G1/S transition in response to corneal debridement. Invest. Ophthalmol. Vis. Sci. 40:1999;1952-1958.
7. Classon M., Dyson N. p107 and p130: versatile proteins with interesting pockets. Exp. Cell Res. 264:2001;135-147.
8. Cotsarelis G., Cheng S.-Z., Dong G., Sun T.-T., Lavker R.M. Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells. Cell. 57:1989;201-209.
9. Dirks P.B., Rutka J.T. Current concepts in neuro-oncology: the cell cycle - a review. Neurosurgery. 40:1997;1000-1013. Discussion 1013-1005.
10. Dulic V., Kaufmann W.K., Wilson S.J., Tisty T.D., Lees E., Harper J.W., Elledge S.J., Reed S.I. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell. 76:1994;1013-1023.
11. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 12:1998;2245-2262.
12. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
13. Evans T., Rosenthal E.T., Youngblom J., Distel D., Hunt T. Cyclin A protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell. 33:1983;389-396.
14. Francesconi C.M., Hutcheon A.E., Chung E.H., Dalbone A.C., Joyce N.C., Zieske J.D. Expression patterns of retinoblastoma and E2F family proteins during corneal development. Invest. Ophthalmol. Vis. Sci. 41:2000;1054-1062.
15. Graham M.A., Rawe I., Dartt D.A., Joyce N.C. Protein kinase C regulation of corneal endothelial cell proliferation and cell cycle. Invest. Ophthalmol. Vis. Sci. 41:2000;4124-4132.
16. Gu Y., Turck C.W., Morgan D.O. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature. 366:1993;707-710.
17. Haaskjold E., Sandvig K.U., Bjerknes R., Kravik K. The early cell kinetic response during healing of corneal epithelial wounds. Ophthalmic. Surg. 23:1992;680-684.
18. Hanna C. Proliferation and migration of epithelial cells during corneal wound repair in the rabbit and the rat. Am. J. Ophthalmol. 61:1966;55-63.
19. INK4b is a potential effector of TGF-b-induced cell cycle arrest. Nature. 371:1994;257-261.
20. Hara J. An autoradiographic study of regeneration of the corneal epithelium. Folia Ophthalmol. 13:1962;443-466.
21. Harper J.W. Cyclin dependent kinase inhibitors. Cancer Surv. 29:1997;91-107.
22. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
23. Hengst L., Reed S.I. Translational control of p27Kip1 accumulation during the cell cycle. Science. 271:1996;1861-1864.
24. Hengst L., Reed S.I. Inhibitors of the Cip/Kip family. Curr. Top. Microbiol. Immunol. 227:1998;25-41.
25. Hulleman E., Boonstra J. Regulation of G1 phase progression by growth factors and the extracellular matrix. Cell Mol. Life Sci. 58:2001;80-93.
26. Hunter T., Pines J. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell. 79:1994;573-582.
27. Joyce N.C., Harris D.L., Mello D.M. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2. Invest. Ophthalmol. Vis. Sci. 43:2002;2152-2159.
28. Joyce N.C., Harris D.L., Zieske J.D. Mitotic inhibition of corneal endothelium in neonatal rats. Invest. Ophthalmol. Vis. Sci. 39:1998;2572-2583.
29. Joyce N.C., Meklir B., Joyce S.J., Zieske J.D. Cell cycle protein expression and proliferative status in human corneal cells. Invest. Ophthalmol. Vis. Sci. 37:1996;645-655.
30. Joyce N.C., Navon S.E., Roy S., Zieske J.D. Expression of cell cycle-associated proteins in human and rabbit corneal endothelium in situ. Invest. Ophthalmol. Vis. Sci. 37:1996;1566-1575.
31. Kim T.Y., Kim W.I., Smith R.E., Kay E.P. Differential activity of TGF-beta2 on the expression of p27Kip1 and Cdk4 in actively cycling and contact inhibited rabbit corneal endothelial cells. Mol. Vis. 7:2001;261-270.
32. Kiyokawa H., Koff A. Roles of cyclin-dependent kinase inhibitors: Lessons from knockout mice. Curr. Top. Microbiol. Immunol. 227:1998;105-120.
33. Lavker R.M., Dong G., Cheng S.Z., Kudoh K., Cotsarelis G., Sun T.-T. Relative proliferative rates of limbal and corneal epithelium: implications of corneal epithelial migration, circadian rhythm, and suprabasally located DNA-synthesizing keratinocytes. Invest. Ophthalmol. Vis. Sci. 32:1991;1864-1875.
34. Lee H.T., Kay E.P. Regulatory role of PI 3-kinase on expression of Cdk4 and p27, nuclear localization of Cdk4, and phosphorylation of p27 in corneal endothelial cells. Invest. Ophthalmol. Vis. Sci. 44:2003;1521-1528.
35. Lee J.-S., Liu J.J., Hong J.-W., Wilson S.E. Differential expression analysis by gene array of cell cycle modulators in human corneal epithelial cells stimulated with epidermal growth factor (EGF), hepatocyte growth factor (HGF), or keratinocyte growth factor (KGF). Curr. Eye Res. 23:2001;69-76.
36. Lee M.H., Reynisdottir I., Massague J. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9:1995;639-649.
37. Massague J., Polyak K. Mammalian antiproliferative signals and their targets. Curr. Opin. Genetics Dev. 5:1995;91-96.
38. Morisaki H., Fujimoto A., Ando A., Nagata Y., Ikeda K., Nakanishi M. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2. Biochem. Biophys. Res. Commun. 240:1997;386-390.
39. Nakayama K., Nakayama K. Cip/Kip cyclin-dependent kinase inhibitors: brakes of the cell cycle engine during development. Bioessays. 20:1998;1020-1029.
40. Nevins J.R. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9:1998;585-593.
41. Nigg E.A. Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays. 17:1995;471-480.
42. Pagano M., Tam S.W., Theodoras A.M., Beer-Romero P., Del Sal G., Chau V., Yew P.R., Draetta G.F., Rolfe M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science. 269:1995;682-685.
43. Pavletich N.P. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J. Mol. Biol. 287:1999;821-828.
44. Peters G. The D-type cyclins and their role in tumorigenesis. J. Cell Sci. 18:1994;89-96. Supplement.
45. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8:1994;9-22.
46. Reed S.I. Control of the G1/S transition. Cancer Surv. 29:1997;7-23.
47. 1 control in mammalian cells. J. Cell Sci. 18:1994;69-73. Supplement.
48. 1-to-S transition. Mol. Cell Biol. 15:1995;3463-3469.
49. Rosenthal E.T., Hunt T., Ruderman J.V. Selective translation of mRNA controls the pattern of protein synthesis during early development of the surf clam. Cell. 20:1980;487-494.
50. Roussel M.F. The INK4 family of cell cycle inhibitors in cancer. Oncogene. 18:1999;5311-5317.
51. Sandvig K.U., Haaskjold E., Bjerknes R., Refsum S.B., Kravik K. Cell kinetics of conjunctival and corneal epithelium during regeneration of different-sized corneal epithelial defects. Acta Ophthalmol (Kbh). 72:1994;43-48.
52. Schonthal A.H., Hwang J.J., Stevenson D., Trousdale M.D. Expression and activity of cell cycle-regulatory proteins in normal and transformed corneal endothelial cells. Exp. Eye Res. 68:1999;531-539.
53. Shatos M.A., Rios J.D., Horikawa Y., Hodges R.R., Chang E.L., Bernardino C.R., Rubin P.A., Dartt D.A. Isolation and characterization of cultured human conjunctival goblet cells. Invest. Ophthalmol. Vis. Sci. 44:2003;2477-2486.
54. Sherr C.J. G1 phase progression: cycling on cue. Cell. 79:1994;551-555.
55. Sherr C.J. D-type cyclins. Trends Biochem. Sci. 20:1995;187-190.
56. Wei Z.G., Cotsarelis G., Sun T.T., Lavker R.M. Label-retaining cells are preferentially located in fornical epithelium: implications on conjunctival epithelial homeostasis. Invest. Ophthalmol. Vis. Sci. 36:1995;236-246.
57. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330.
58. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 366:1993;701-704.
59. Yoshida K., Nakayama K., Nagahama H., Harada T., Harada C., Imaki J., Matsuda A., Yamamoto K., Ito M., Ohno S. Involvement of p27(KIP1) degradation by Skp2 in the regulation of proliferation in response to wounding of corneal epithelium. Invest. Ophthalmol. Vis. Sci. 43:2002;364-370.
60. Zagon I.S., Sassani J.W., Ruth T.B., McLaughlin P.J. Cellular dynamics of corneal wound re-epithelialization in the rat. III. Mitotic activity. Brain Res. 882:2000;169-179.
61. KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature. 387:1997;151-158.
62. Zieske J.D. Expression of cyclin-dependent kinase inhibitors during corneal wound repair. Prog. Retin Eye Res. 19:2000;257-270.
63. Zieske J.D., Gipson I.K. Agents that affect corneal wound healing: modulation of structure and function. Albert D.M., Jakobiec F.A. Principles and Practice of Ophthalmology. 1994;1093-1099 W.B. Saunders, Philadelphia.
64. Zieske J.D., Guimaraes S.R., Hutcheon A.E. Kinetics of keratocyte proliferation in response to epithelial debridement. Exp. Eye Res. 72:2001;33-39.